U.S. biotech to apply artificial intelligence to UK genome study

CHICAGO, Sept 30 (Reuters) - Berg, a private company that uses artificial intelligence to discover new drugs and diagnostics, will help England's national genomics project mine DNA and health data from thousands of British citizens for potential drug targets.